Business concerns in the West often make money by patenting their own medicines and agricultural products based on the traditional knowledge of indigenous peoples.
A US company has patented a yellow bean grown for thousands of years in South America, while pesticides using substances from the Indian neem tree have been sold by transnational corporations in Europe and elsewhere.
A firm in Germany is marketing a cure for respiratory ailments based on extracts from the African Pelargonium plant genus.
Some of these patents have been returned after years of litigation, but that is not enough for some participants at the UN conference on biodiversity, which takes place in Bonn, Germany, tomorrow through May 30.
The UN gathering wants to make traditional knowledge less vulnerable to unauthorized use and ensure that adequate financial compensation is made to the communities that possess such knowledge.
“The foundation stone has to be laid so that we can come to a concrete agreement by 2010,” said Konrad Uebelhoer, biodiversity director at the German Society for Technical Cooperation (GTZ).
One of the main demands, he said, is that business and researchers be required to seek permission in the individual countries before they start searching for medicinal plants or genes.
The local communities should also be consulted in the application of traditional knowledge, which is based on practice and has often been passed on through many generations.
“It is necessary to have a clear formula for profit-sharing,” Uebelhoer said.
This could also include transferring the technology used to identify the active ingredients to the countries of origin, he said.
About 190 nations have signed up to the UN Convention on Biological Diversity. The only industrialized nation that has not joined is the US.
Washington does not object to the first two goals of the convention — the protection of biodiversity and its sustainable development, Uebelhoer said.
It is the third aim of justly distributing the profits from the use of biological agents that has run into opposition from the powerful US pharmaceutical industry, he said.
Andreas Drews, who also works for the GTZ, said those applying for patents were not required to state where the biological ingredients come from, leading to an undetermined amount of biopiracy.
He wants changes made to the way patents are granted in order to stop this practice.
“We demand a formal disclosure of where the resources come from before biological ingredients, novel food and cosmetics can be registered,” he said.
“Novel food” is the term used for new foodstuffs, in particular genetically modified foods.
This is already the case in Norway, said Drews, whose organization is responsible for carrying out projects authorized by the German Ministry for Economic Cooperation and Development.
There has already been some success in ensuring that some of the wealth gained from derivatives of traditional knowledge is returned to the holders of that knowledge.
Among the beneficiaries are the San people in southern Africa, said Frank Barsch, an expert on the protection of species at the environmental organization WWF.
These hunter-gatherers chew the cactus-like hoodia plant to still hunger and thirst pangs on their long journeys through the inhospitable Kalahari desert.
The South African Council for Scientific and Industrial Research (CSIR) isolated the appetite suppressant P57 contained in the plant and patented it as a dietary supplement. Dutch-based Unilever is now developing the product.
After much protest, CSIR signed a deal with the San in 2003 on sharing the potential benefits of the product, which is being touted as a potential cure for obesity.
Under the deal, to which Unilever is expected to contribute from next year, San communities will be able to access royalties from a trust fund to finance social projects.
SECURITY: Taipei presses the US for arms supplies, saying the arms sales are not only a reflection of the US security commitment to Taiwan but also serve as a mutual deterrent against regional threats Taiwan is committed to preserving the cross-strait “status quo” and contributing to regional peace and stability, the Presidential Office said yesterday. “It is an undeniable fact that the Republic of China is a sovereign and independent democratic nation,” Presidential Office spokeswoman Karen Kuo (郭雅慧) reiterated, adding that Beijing has no right to claim sovereignty over Taiwan. The statements came after US President Donald Trump warned against Taiwanese independence. Trump wrapped up a state visit to Beijing on Friday, during which Chinese President Xi Jinping (習近平) had pressed him not to support Taiwan. Taiwan depends heavily on US security backing to deter China from carrying
The subsidiary of Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in Kumamoto, Japan, turned a profit in the first quarter of this year, marking the first time the first fab of the unit has become profitable since mass production started at the end of 2024. According to the contract chipmaker’s financial statement released on Friday, Japan Advanced Semiconductor Manufacturing Inc (JASM), a joint venture running the fab in Kumamoto, posted NT$951 million (US$30.19 million) in profit in the January-to-March period, compared with a loss of NT$1.39 billion in the previous quarter, and a loss of NT$3.25 billion in the first quarter of
RESOLUTE BACKING: Two Republican senators are planning to introduce legislation that would impose immediate sanctions on China if it attempts to invade Taiwan US House of Representatives Speaker Mike Johnson on Sunday reaffirmed US congressional support for Taiwan, saying the US and “all freedom-loving people” have a stake in preventing China from seizing Taiwan by force. Johnson made the remarks in an interview with Fox News Sunday on US President Donald Trump’s summit with Chinese President Xi Jinping (習近平) last week. In an interview that aired on Friday on Fox News, just as Trump wrapped up a high-stakes visit to China, he said he has yet to green-light a new US$14 billion arms package to Taiwan and that it “depends on China.” “It’s a very good
US President Donald Trump yesterday said he would speak to President William Lai (賴清德) as his administration considers whether to move ahead with a US$14 billion weapons sale to Taiwan — a potential arms deal that has drawn criticism from China. “Well, I’ll speak to him. I speak to everybody,” Trump told reporters yesterday when asked if he had any plans to call his counterpart, although he did not offer a time frame for when such a conversation could take place. Trump previously said he would speak to the person “that’s running Taiwan,” without specifying who he meant. “We have that situation very